Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alabama wins second Medicaid fraud verdict

Executive Summary

An Alabama state court jury finds GlaxoSmithKline and Novartis liable for $80.9 million and $33.2 million in compensatory damages, respectively, for inflating the average wholesale prices of prescription drugs. GSK and Novartis announced they would appeal the verdict. The Attorney General of Alabama has sued 79 pharmaceutical companies for overcharging the state Medicaid agency. In February a jury issued a $215 million verdict against AstraZeneca, which a judge subsequently reduced to $160 million (1"The Pink Sheet," June 23, 2008, In Brief)
Advertisement

Related Content

Three AWP Verdicts Overturned By Alabama Supreme Court; Ruling Could End 70 Other Suits
AstraZeneca Medicaid fraud verdict
Advertisement
UsernamePublicRestriction

Register

PS049827

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel